banner

DTC Lifts Chill on Shares of Universal Bioenergy

On July 22, the Depository Trust Company, or DTC, imposed a “deposit chill” on shares of Universal Bioenergy Inc. (OTCQB: UBRG), an  independent diversified energy company that produces and markets natural gas, petroleum, coal and propane.

Universal Bioenergy (UBRG)

DTC, the largest securities depository in the world with 3.6 million securities worth $35 trillion on deposit, was created by the securities industry to improve efficiencies and reduce risk in the clearance and settlement of securities transactions.

A DTC chill can happen for a variety of reasons and entails a restriction of one type or another in DTC services.  It is unlike a “freeze” wherein all DTC services are discontinued until compliance is met or the security is completely removed from DTC listing.

In the case of Universal Bioenergy, the DTC requested that company demonstrate that the sale and transfer of certain shares of its common stock, were made pursuant to an effective registration statement under the Securities Act, or the shares did not require registration thereunder. Universal’s independent legal counsel provided full documentation to the DTC, to the effect that the shares were freely tradable without restriction under the securities laws, according to today’s corporate statement.



To that end, all DCT restrictions have been removed, the DTC is again accepting deposits of UBRG for book entry transfer services and the stock has resumed full electronic trading.  Generally speaking, this should improve liquidity in the stock, but the restriction did little to crimp daily trading volumes in the Irvine, California-based company.

“Although many had doubts, management made promises to use every effort to gain approval to remove the Chill, and we were successful,” said Solomon Ali, Universal’s Senior Vice President.

Shares of UBRG slipped during the DTC chill to lows of $0.0031 in mid-September, but rebounded to hit a high of 1.15 cents in the opening days of October before fading back into sub-penny range.  Today, shares are ahead by 25.49 percent halfway through the trading day; printing $0.006 on 1.7 million in volume.

Universal Bioenergy (UBRG) Stock Quote and News:







Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Prior compensation is listed in our full disclosure. Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.

0 comments

Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Stocks Mixed on Monday

Stocks Mixed on Monday(0)

The Dow Jones industrial average topped 16,000 for the first time ever Monday, while the S&P 500 briefly surpassed 1,800. The Dow retreated from the 16,000 level, but still gained 14.32 points from Friday”s all-time high close, to 15,976. The S&P 500 index dipped 6.65 points to 1,791.53. The NASDAQ fell 36.90 points to 3,949.07

Catalyst Pharmaceutical Partners Stock Chart Analysis Video

Catalyst Pharmaceutical Partners Stock Chart Analysis Video(0)

The Catalyst Pharmaceutical Partners (NASDAQ: CPRX) stock chart formed a piercing line reversal pattern on Wednesday and Thursday that was confirmed with a sharp move upwards on Friday. Technical traders will be watching support around the 200 day moving average at $1.25 on any pullback, but for the time being, the chart looks to be

EnteroMedics Stock Chart Analysis Video

EnteroMedics Stock Chart Analysis Video(0)

The EnteroMedics (NASDAQ:ETRM) chart has been making higher highs and higher lows since forming a double bottom early in the year. The chart is holding over the 50-day moving average and inching higher each day as it tries to gain momentum to make the next leg up in the channel. EnteroMedics is a medical device

NXT-ID Authentication Using Face and Voice Recognition

NXT-ID Authentication Using Face and Voice Recognition(0)

There’s a Wocket in My Pocket! may soon not just be a sentence from the mouths of children after reading the rhyming book by Dr. Seuss. There was plenty of made-up ridiculousness in the iconic book, such as a bofa on the sofa, but there is nothing fictitious about the Wocket, a next-generation payment and

Dow Not Tired of Making New Record Highs

Dow Not Tired of Making New Record Highs(0)

The Dow Jones Industrials will have to wait till at least next week to mount the lofty heights of 16,000 points, but both the Dow and the S&P did end the day at record highs. The Dow Jones Industrials was up 85.48 points from yesterday”s all-time high, to close at 15,961.70 The S&P 500 index

read more
banner

Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.